Serina Therapeutics, Inc.
SER
$1.77
-$0.13-6.84%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.77% | 27.24% | 28.89% | -33.97% | -75.66% |
| Total Depreciation and Amortization | -25.00% | 50.00% | 0.00% | -5.88% | -69.64% |
| Total Amortization of Deferred Charges | 10.34% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 202.84% | -149.93% | -134.26% | 10,300.00% | 101.09% |
| Change in Net Operating Assets | 146.73% | -177.87% | 97.73% | 55.16% | 364.53% |
| Cash from Operations | 24.28% | -56.70% | -2.67% | 13.23% | 5.82% |
| Capital Expenditure | -- | 100.00% | 71.74% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 71.74% | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 382.81% | 252.51% | 143.02% | 62,900.00% | -99.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | 5,317.26% | -92.54% | 15.69% | 13.28% | -2.27% |
| Foreign Exchange rate Adjustments | 150.00% | -500.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 485.87% | -315.74% | 45.38% | 198.15% | 36.16% |